Understanding the Influenza Virus: Structure, Transmission and Epidemiological Success

Written by Oliver Dsa MSc, senior virologist at Airmid Healthgroup, where he leads testing and research on airborne pathogens, indoor air quality, and antiviral technologies in real-world environments.

Microscopic image of H1N1 influenza virus particles showing viral envelope and structure
3D Representation of Influenza Structure Image courtesy of CDC Cynthia Goldsmith

Influenza viruses are highly contagious pathogens responsible for seasonal flu outbreaks and historic global pandemics. These viruses can cause symptoms ranging from mild respiratory illness to severe, life-threatening disease. Understanding the structure, classification, and transmission of the influenza virus is essential for effective prevention and control—especially in indoor environments.

Classification and Structure of the Influenza Virus

Influenza viruses are part of the Orthomyxoviridae family, which includes six genera. The three types most relevant to human and animal health are Influenza A, B, and C:

  • Influenza A infects humans and animals and is responsible for all known flu pandemics.
  • Influenza B primarily affects humans and causes seasonal flu outbreaks.
  • Influenza C results in mild respiratory illness.

Each influenza virus is an enveloped RNA virus, about 100 nanometers in diameter, featuring two key surface proteins: hemagglutinin (H) and neuraminidase (N). These proteins are used to subtype Influenza A viruses (e.g., H1N1, H3N2). For example, H1N1, the subtype behind the 2009 “swine flu” pandemic, had previously caused the deadly 1918 Spanish flu pandemic.

What Makes Influenza A So Versatile?

One of the reasons Influenza A viruses are so successful is their ability to mutate and evolve. This includes:

  • Antigenic drift: gradual point mutations in H and N proteins, reducing immune recognition.
  • Antigenic shift: genetic reassortment between strains, often leading to new pandemics.
  • Zoonotic transmission: infection from animals (especially birds and pigs) to humans.

Wild birds act as natural reservoirs, but cross-species transmission can occur to pigs, poultry, and marine mammals. When influenza viruses adapt to human-to-human transmission, they can rapidly spread globally.

How is Influenza Transmitted?

Influenza is spread through:

  • Respiratory droplets from sneezing or coughing
  • Aerosolized particles that remain suspended in indoor air
  • Contaminated surfaces, particularly non-porous materials

In indoor environments, influenza A virus has been shown to remain infectious on surfaces for hours, and airborne virus particles have been detected in airplane cabins, public buildings, healthcare settings, and day-care centers.

Factors like ventilation, humidity, and temperature play critical roles in virus survival and transmission indoors, making indoor air quality a vital part of infection control.

 

Related Airmid Blogs:

Related Tests at Airmid

Infection Control & Antimicrobial Technologies Testing Services

BS EN 13610:2002: Quantatative suspension test for the evaluation of virucidal activity against bacteriophages of chemical disinfectants used in food and industrial areas.

BS ISO 16869:2008: Assessment of the effectiveness of fungistatic compounds in plastics formulations.

ASTM E2149-13a: Standard test method for determining the antimicrobial activity of immobilized antimicrobial agents under dynamic contact conditions.

Microbiology Laboratory

Related Case Studies

Airmid Validates Fellowes® AeraMax™ Air Purifiers for Removing Cold and Flu Viruses

Airmid Validates the HygieneShield™ Range by Beko for Eliminating 99.9% of Bacteria and Viruses

 Keywords

influenza virus, H1N1, airborne virus transmission, virus mutation, indoor air quality, orthomyxoviridae, flu pandemic, virus structure, virus surface proteins, zoonotic flu, airmid virology

Do you want to validate your technology?

Contact the Airmid Healthgroup team today to learn more about the independent testing process and how it can enhance your product’s credibility in the market.

Click Here

author avatar
Oliver Dsa MSc

Oliver Dsa, MSc, is a senior scientist at Airmid Healthgroup and a leading specialist in environmental virology and the transmission dynamics of airborne pathogens. With extensive experience in high-containment laboratory research and virological assay development, Oliver plays a central role in the design and execution of GLP-compliant studies that evaluate the real-world performance of antimicrobial, antiviral, and air purification technologies.

At Airmid Healthgroup, Oliver’s work supports global manufacturers, healthcare innovators, and regulatory teams by generating scientifically robust data that withstands scrutiny from FDA, EPA, ISO, and CE marking bodies. He is deeply engaged in testing solutions for infection prevention across healthcare, residential, commercial, and transport environments.

Through his contributions to Airmid’s blog, Oliver translates complex virology and bioaerosol science into actionable insights.

His writing supports product developers, indoor air quality experts, and public health professionals in navigating the fast-evolving intersection of airborne disease control, ventilation standards (including ASHRAE 241), and surface decontamination strategies.

In his blog contributions, Oliver breaks down complex scientific issues—ranging from airborne pathogens to surface decontamination and beyond—into clear, actionable insights for professionals in healthcare, building science, consumer product development, and public health.

Scroll to Top